Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Exposure to household air pollution from using wood or coal for cooking and heating is associated with higher risk of death from heart attack and stroke, according to new research published in the Journal of the American Medical Association (JAMA).

Image courtesy of Shutterstock

Around three billion people worldwide use solid fuels (e.g. coal, wood, charcoal and crop wastes) to cook and to heat their homes. When burnt, these fuels produce smoke that contains a very high concentration of fine particles (known as PM2.5) and other harmful substances, especially in houses without adequate ventilation.

It is estimated that worldwide about 2.5 million deaths in 2016 were related to the resulting household air pollution. In China, despite rapid urbanisation in recent decades, about one in three people still rely heavily on solid fuels, mostly coal and wood, for domestic purposes. The health impact of household air pollution on the Chinese population is therefore believed to be substantial, but previous research has not provided concrete evidence.

Researchers from the University of Oxford, Huazhong University of Science and Technology, the Chinese Academy of Medical Sciences, and Peking University in China have studied the association of the long-term use of solid fuels for cooking and heating with the risk of death from cardiovascular disease in a large study of 271,000 residents in five rural areas in China.

Find out more (University of Oxford website)

Similar stories

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.

Increased infectiousness of coronavirus variants explained

Researchers from the Universities of Oxford and Dundee have made a discovery that helps explain why variations in the virus causes COVID-19 to spread so rapidly.

RECOVERY Trial paper wins BMJ’s 2021 UK Research Paper of the Year Award

For the second year in a row, The British Medical Journal have selected a publication co-authored by Oxford University researchers for their prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare.

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.